Innovus receives approval for expanded label Indication for Zestra(R) in Canada
Innovus Pharmaceuticals announced that it has received approval from Health Canada for an expanded label for its marketed Zestra(R) product. Zestra(R) is currently approved and marketed in Canada for the indication of Temporary Increase of Desire in Female Sexual Desire Disorder Women. October 24, 2014